loadpatents
name:-0.03204083442688
name:-0.014611005783081
name:-0.01454496383667
MOELLEKEN; Joerg Patent Filings

MOELLEKEN; Joerg

Patent Applications and Registrations

Patent applications and USPTO patent grants for MOELLEKEN; Joerg.The latest application filed is for "antibodies which bind to cancer cells and target radionuclides to said cells".

Company Profile
13.13.30
  • MOELLEKEN; Joerg - Penzberg DE
  • Moelleken; Joerg - Munich DE
  • Moelleken; Joerg - Muenchen DE
  • Moelleken; Joerg - Heidelberg DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibodies Which Bind To Cancer Cells And Target Radionuclides To Said Cells
App 20220267463 - UMANA; Pablo ;   et al.
2022-08-25
Antibody That Binds To Vegf-a And Ang2 And Methods Of Use
App 20220073599 - Beckmann; Roland ;   et al.
2022-03-10
Antibody That Binds To Vegf And Il-1beta And Methods Of Use
App 20220041707 - BECKMANN; ROLAND ;   et al.
2022-02-10
Method For Improving Inhibition Of Vegf-binding To Vegf-r1 Of An Anti-vegf Antibody
App 20220002397 - Benz; Joerg ;   et al.
2022-01-06
Antibodies specific for DR5 and methods of use
Grant 11,214,622 - Bruenker , et al. January 4, 2
2022-01-04
Antibody that binds to VEGF and IL-1beta and methods of use
Grant 11,130,804 - Beckmann , et al. September 28, 2
2021-09-28
Spr-based Bridging Assay Format For Determining The Biological Activity Of Multivalent, Multispecific Molecules
App 20210199666 - Papadimitriou; Apollon ;   et al.
2021-07-01
Method For Determining The In Vivo Interaction Mode
App 20210198383 - MOELLEKEN; Joerg ;   et al.
2021-07-01
Direct Affinity Measurement Of Human Igg1 Binding Multimeric Antigens
App 20210199653 - MOLHOJ; Michael ;   et al.
2021-07-01
Bispecific Anti-ccl2 Antibodies
App 20210188960 - FISCHER; Jens ;   et al.
2021-06-24
Multispecific Antibodies And Use Thereof
App 20210147554 - DENGL; Stefan ;   et al.
2021-05-20
Anti-hla-g Antibodies And Use Thereof
App 20210147553 - DENGL; Stefan ;   et al.
2021-05-20
Humanized Anti-tau(ps422) Antibodies And Methods Of Use
App 20210139571 - Dengl; Stefan ;   et al.
2021-05-13
Anti-vegf Anitbodies And Methods Of Use
App 20210079080 - Dengl; Stefan ;   et al.
2021-03-18
Method For Improving Vegf-receptor Blocking Selectivity Of An Anti-vegf Antibody
App 20210047395 - Benz; Joerg ;   et al.
2021-02-18
Humanized anti-tau(pS422) antibodies and methods of use
Grant 10,822,402 - Dengl , et al. November 3, 2
2020-11-03
Bispecific antibodies and methods of use in ophthalmology
Grant 10,730,938 - Bedoucha , et al.
2020-08-04
Antibody That Binds To Vegf And Il-1beta And Methods Of Use
App 20200199214 - BECKMANN; ROLAND ;   et al.
2020-06-25
Anti-ANG2 antibodies and methods of use
Grant 10,538,585 - Dengl , et al. Ja
2020-01-21
SPR-based dual-binding assay for the functional analysis of multispecific molecules
App 20190317086 - Gassner; Christian ;   et al.
2019-10-17
TNFa-IL-17 bispecific antibodies
Grant 10,329,346 - Auer , et al.
2019-06-25
Bispecific Antibodies Specific For Fap And Dr5, Antibodies Specific For Dr5 And Methods Of Use
App 20190062453 - Bruenker; Peter ;   et al.
2019-02-28
Direct Affinity Measurement Of Human Igg1 Binding Multimeric Antigens
App 20190018009 - MOLHOJ; Michael ;   et al.
2019-01-17
Method For Determining The In Vivo Interaction Mode
App 20190016827 - MOELLEKEN; Joerg ;   et al.
2019-01-17
Anti-PDGF-B antibodies and methods of use
Grant 10,087,246 - Bedoucha , et al. October 2, 2
2018-10-02
Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5
Grant 9,926,379 - Bruenker , et al. March 27, 2
2018-03-27
Humanized Anti-tau(ps422) Antibodies And Methods Of Use
App 20180079804 - Dengl; Stefan ;   et al.
2018-03-22
Humanized anti-tau(pS422) antibodies and methods of use
Grant 9,862,763 - Dengl , et al. January 9, 2
2018-01-09
Anti-pdgf-b Antibodies And Methods Of Use
App 20170247440 - Bedoucha; Marc ;   et al.
2017-08-31
Anti-ang2 Antibodies And Methods Of Use
App 20170247441 - Dengl; Stefan ;   et al.
2017-08-31
Bispecific Antibodies And Methods Of Use In Ophthalmology
App 20170240629 - Bedoucha; Marc ;   et al.
2017-08-24
Bispecific antibodies against human TWEAK and human IL17 and uses thereof
Grant 9,714,292 - Auer , et al. July 25, 2
2017-07-25
Spr-based Bridging Assay Format For Determining The Biological Activity Of Multivalent, Multispecific Molecules
App 20170003295 - Papadimitriou; Apollon ;   et al.
2017-01-05
HUMANIZED ANTI-TAU(pS422) ANTIBODIES AND METHODS OF USE
App 20160376352 - Dengl; Stefan ;   et al.
2016-12-29
Tnfa-il-17 Bispecific Antibodies
App 20160326241 - AUER; JOHANNES ;   et al.
2016-11-10
Antibodies against human IL33R and uses thereof
Grant 9,309,319 - Fertig , et al. April 12, 2
2016-04-12
Bispecific Antibodies Against Human Tweak And Human 1l17 And Uses Thereof
App 20150132307 - AUER; JOHANNES ;   et al.
2015-05-14
Bispecific Antibodies Specific For Fap And Dr5, Antibodies Specific For Dr5 And Methods Of Use
App 20140370019 - Bruenker; Peter ;   et al.
2014-12-18
Antibodies Against Human Il33r And Uses Thereof
App 20140302015 - Fertig; Georg ;   et al.
2014-10-09
Antibodies against human IL33R and uses thereof
Grant 8,785,153 - Fertig , et al. July 22, 2
2014-07-22
Antibodies against human IL33R and uses thereof
App 20120213774 - Fertig; Georg ;   et al.
2012-08-23
A (X - 38 .. 43) oligomers, and processes, compositions, and uses thereof
App 20100173828 - Hillen; Heinz ;   et al.
2010-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed